<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for GILD</title>
    <link />
    <description>Headlines for Gilead Sciences</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Gilead's Sofosbuvir under European Review - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99955/gileads-sofosbuvir-under-european-review.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 22 May 2013 21:25:01 GMT</pubDate>
    </item>
    <item>
      <title>Tiger Cub John Griffin's Top Stock Picks For Q2</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1453381-tiger-cub-john-griffin-s-top-stock-picks-for-q2.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 11:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Stock Hits New 52-Week High (GILD)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11931071/1/gilead-stock-hits-new-52-week-high-gild.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 22 May 2013 10:33:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130522-000419&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Wed, 22 May 2013 09:00:59 GMT</pubDate>
    </item>
    <item>
      <title>Pre-Market Most Active for May 22, 2013 :  NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD,</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/premarket-most-active-for-may-22-2013-ntap-pfe-nmr-rdsa-rdsb-nok-sne-pgti-irwd-gild-vod-znga-cm247769.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Wed, 22 May 2013 08:39:56 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Hepatitis C Drug Gets Accelerated Review</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130521-000456&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Tue, 21 May 2013 17:44:59 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Hepatitis C Drug Sofosbuvir Granted Accelerated Review in Europe</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130521-000447&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Tue, 21 May 2013 17:29:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences Inc (GILD): Today's Featured Drugs Winner</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11930336/1/gilead-sciences-inc-gild-todays-featured-drugs-winner.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 21 May 2013 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/european-medicines-agency-validates-gileads-market/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 16:50:13 GMT</pubDate>
    </item>
    <item>
      <title>Will Influenza A H7N9 Generate Opportunities For Pharma?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1449531-will-influenza-a-h7n9-generate-opportunities-for-pharma.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 21 May 2013 09:10:48 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLA</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11927299/1/cramers-top-stock-picks-save-gild-bmy-hta-tsla.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 21 May 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447611-gilead-sciences-management-presents-at-the-2013-ubs-global-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 13:34:03 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928285/1/5-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Leukemia's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/tackling-cancer-leukemias-biggest-current-upcoming/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 18:30:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/3-horrendous-health-care-stocks-this-week-28/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 08:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/gilead-sciences-to-present-at-the-2013-ubs-global-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 16:20:50 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Lightning Round - I've Had It With Magnum Hunter (5/16/13)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1443001-cramer-s-lightning-round-i-ve-had-it-with-magnum-hunter-5-16-13.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 17 May 2013 06:20:48 GMT</pubDate>
    </item>
    <item>
      <title>'Mad Money' Lightning Round: Magnum Hunter Blew It</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11925148/1/mad-money-lightning-round-magnum-hunter-blew-it.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 17 May 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Pipeline Progress at Gilead - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99568/pipeline-progress-at-gilead.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 16 May 2013 14:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Meeting Highlights the Good and Bad of the Immune System</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/cancer-meeting-highlights-the-good-and-bad-of-the/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 19:10:00 GMT</pubDate>
    </item>
  </channel>
</rss>
